Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Novitas Capital

Founders Michael G. Bolton

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 42
Average round size
info
The average size of a deal this fund participated in
$11M
Portfolio companies 28
Rounds per year 1.62
Lead investments 5
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 15
Key employees 2
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Software
  • Internet
  • Medical
Summary

In 1997 was created Novitas Capital, which is appeared as VC. The main office of represented VC is situated in the Wayne. The venture was found in North America in United States.

The fund was created by Michael G. Bolton. The overall number of key employees were 2.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Novitas Capital, startups are often financed by Ben Franklin Technology Partners of Northeastern Pennsylvania, Morgan Stanley, Technology Venture Partners. The meaningful sponsors for the fund in investment in the same round are Safeguard Scientifics, EuclidSR Partners, Battelle Ventures. In the next rounds fund is usually obtained by Ben Franklin Technology Partners of Northeastern Pennsylvania, Morgan Stanley, EuclidSR Partners.

The fund is constantly included in 2-6 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2000. The real fund results show that this VC is 2 percentage points less often commits exit comparing to other companies. The top amount of exits for fund were in 2011. Comparing to the other companies, this Novitas Capital performs on 7 percentage points more the average number of lead investments.

Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Enterprise Software. Among the most popular portfolio startups of the fund, we may highlight TetraLogic Pharmaceuticals, E-Duction, Logical Therapeutics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Novitas Capital:
Typical Co-investors
Novitas Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Novitas Capital:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Angellist-RH V5-Fund -
Emfato Holdings -
Hanhua Ziben Beijing, Beijing, China
Healthworx Baltimore, Maryland, United States
Langtaosha Investment Management China, Hangzhou, Zhejiang
Ornament -
Shennong Capital Beijing, China, Haidian
Southland Industries California, Garden Grove, United States
Tristone Capital Houston, Texas, United States
Xunqi Liancheng Business Service Beijing, China, Haidian

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Cernostics

Biotechnology
Health Diagnostics
Life Science
Medical Device
$1M03 Dec 2013 Pennsylvania, United States

Agile Therapeutics

Biotechnology
Health Care
Women's
$40M19 Jul 2012 New Jersey, United States

TetraLogic Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$23M04 Jan 2011 Pennsylvania, United States

TetraLogic Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$32M10 Aug 2010 Pennsylvania, United States

Agile Therapeutics

Biotechnology
Health Care
Women's
$45M14 Jun 2010 New Jersey, United States

Cernostics

Biotechnology
Health Diagnostics
Life Science
Medical Device
$2M02 Jun 2010 Pennsylvania, United States

Logical Therapeutics

Biotechnology
Health Care
Medical
$16M27 May 2010 Massachusetts, United States

Nistica

Manufacturing
Optical Communication
Web Hosting
$6M22 Mar 2010 New Jersey, United States

TOA Technologies

Enterprise Software
SaaS
Software
Telecommunications
$13M03 Jun 2008 Ohio, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Novitas Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 42
Average round size 11M
Rounds per year 1.62
Peak activity year 2000
Lead investments 5
Follow on index 0.33
Exits 15
Group Appearance index 0.95

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Cernostics

Biotechnology
Health Diagnostics
Life Science
Medical Device
$1M03 Dec 2013 Pennsylvania, United States

Agile Therapeutics

Biotechnology
Health Care
Women's
$40M19 Jul 2012 New Jersey, United States

TetraLogic Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$23M04 Jan 2011 Pennsylvania, United States

TetraLogic Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$32M10 Aug 2010 Pennsylvania, United States

Agile Therapeutics

Biotechnology
Health Care
Women's
$45M14 Jun 2010 New Jersey, United States

Cernostics

Biotechnology
Health Diagnostics
Life Science
Medical Device
$2M02 Jun 2010 Pennsylvania, United States

Logical Therapeutics

Biotechnology
Health Care
Medical
$16M27 May 2010 Massachusetts, United States

Nistica

Manufacturing
Optical Communication
Web Hosting
$6M22 Mar 2010 New Jersey, United States

TOA Technologies

Enterprise Software
SaaS
Software
Telecommunications
$13M03 Jun 2008 Ohio, United States
Crunchbase icon

Content report

The following text will be sent to our editors: